Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Port Charlotte › NPI 1619233509
Physician

Cepero Pediatrics, P.A.

Cepero Pediatrics, P.A. was paid $4.29M by Medicaid between Jan 2019 and Nov 2024, across 66 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.

33Billing provider infoCEPERO PEDIATRICS, P.A.
PORT CHARLOTTE, FL 33952
33aNPI1619233509assigned 04/05/2012
33bProvider typePediatrics Physician
28Total paid$4.29M
24GClaims116,036
24DCodes billed66
24AFirst – last monthJan 2019 – Nov 2024
Compared with peers

Next to other Pediatrics Physician providers in Florida

Rank by total paid#81 of 971
Median peer was paid$238K
This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201922,825$559K
202018,327$495K
202123,951$1.12M
202221,398$951K
202320,003$834K
2024incomplete9,532$334K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 29% 21,305 18,593 $1.24M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 23% 10,026 9,189 $977K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 15% 4,712 4,655 $637K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 10% 3,469 3,324 $440K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 7.9% 2,795 2,765 $339K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 3.6% 1,258 1,241 $155K
90460 Immunization administration through 18 years of age via any route, first or only component 3.3% 7,427 7,261 $142K
90461 1.5% 4,108 4,023 $65K
97802 1.2% 4,135 4,083 $52K
90670 1.0% 2,257 2,213 $44K
90716 <1% 1,239 1,225 $31K
99188 <1% 2,996 2,935 $30K
54 more codes
99381 <1% 251 $23K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 6,605 $15K
90671 <1% 271 $14K
92567 <1% 1,823 $11K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 388 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,734 $7K
83655 <1% 1,914 $7K
81003 <1% 5,202 $7K
87430 <1% 388 $5K
90651 <1% 284 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 866 $5K
17110 <1% 81 $4K
99203 Doctor's office visit, new patient (routine) <1% 78 $3K
96127 <1% 992 $3K
85018 <1% 3,012 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 442 $3K
94667 <1% 298 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 571 $2K
87400 <1% 159 $2K
87428 <1% 55 $2K
90686 <1% 1,514 $2K
87807 <1% 722 $1K
90734 <1% 139 $1K
90619 <1% 30 $945.05
90697 <1% 664 $683.35
96160 <1% 587 $660.26
90707 <1% 1,233 $560.33
90696 <1% 347 $498.50
94664 <1% 196 $488.01
69210 <1% 232 $435.59
90633 <1% 1,546 $410.73
81025 <1% 57 $347.15
90620 <1% 52 $243.76
90685 <1% 99 $178.72
92551 <1% 4,223 $141.18
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 12 $130.68
36416 <1% 2,723 $123.91
87420 <1% 12 $98.34
94760 <1% 51 $84.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 46 $47.48
90723 <1% 1,269 $40.00
90680 <1% 1,940 $30.00
96161 <1% 52 $10.28
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 37 $2.92
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 159 $0.24
90647 0% 1,356 $0.00
90677 0% 203 $0.00
99173 0% 1,254 $0.00
90700 0% 351 $0.00
90715 0% 53 $0.00
99051 0% 13 $0.00
90621 0% 16 $0.00
99177 0% 3,681 $0.00
99401 0% 26 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCEPERO, BELKIS (PEDIATRICIAN)